Maven
Marketing Effectiveness Platform for Pharma
Pharmaceutical companies spend millions on marketing campaigns to reach the right physicians at the right time. As marketing channels evolve, the traditional yearly campaign planning approach is becoming outdated. Brand teams now prefer frequent ROI assessments for agile realignment.
Although frequent measurement sounds ideal, marketing mix modeling is often time-consuming, tedious, and error-prone. A streamlined, state-of-the-art process is needed — one that can run effortlessly with minimal human intervention.
Maven combines human and machine intelligence to accelerate pharma marketing effectiveness. It integrates industry-leading algorithms while supporting client-specific techniques and data systems.
Maven allows pharma teams to conduct ROI analyses quickly across multiple campaigns at scale, ensuring optimal budget allocations backed by analytics.
A single seamless platform supports every need of brand teams — from ROI measurement to fast, informed decision-making.
Downloads
Flyer
Product Features
- Automated ROI analysis with an intuitive interface
- Secure and scalable architecture hosted on AWS for handling large and complex processing
- Historical results and benchmarks can be stored and retrieved
- Multiple iterations with varying parameters can be run and analyzed
- Easy visualization of summaries and results across modules
- ROI optimization and budget allocation
- Saving and retrieval of results
- Project-ready datasets in a few clicks with the powerful 'Data Playground' module
Business Benefits
- Faster insights — ROI analysis in minutes rather than days or weeks, allowing users to measure multiple campaigns in a year
- Reduces the cost of analytics to a fraction of existing costs
- Scalable to other brands, tactics, and data types
- Flexible to incorporate client-specific ROI processes, approaches, techniques, and data systems
- More control in user's hand to arrive at optimal and accurate solution
- Data playground module allows workflow execution at regular intervals
No success stories available at the moment.